A critical role of tumor necrosis factor (TNF) alpha in experimental group A streptococcal (GAS) bacteremia.
Stevens
D L
DL
VA Medical Center, Boise, Idaho, USA.
Bryant
A E
AE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D016470:Bacteremia / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D002443:Ceftriaxone / Q000008:administration & dosage; D002511:Cephalosporins / Q000008:administration & dosage; D016207:Cytokines / Q000097:blood; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D008233:Lymphotoxin-alpha / Q000037:antagonists & inhibitors / Q000097:blood / Q000502:physiology*; D008297:Male; D010215:Papio; D013290:Streptococcal Infections / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D013297:Streptococcus pyogenes / Q000145:classification / Q000472:pathogenicity / Q000502:physiology
D000911:Antibodies, Monoclonal; D002511:Cephalosporins; D016207:Cytokines; D008233:Lymphotoxin-alpha; D002443:Ceftriaxone